Chimerix announced the promotion of Mike Andriole, chief business officer and CFO, to president and CEO of Chimerix and his appointment to the board of directors. Andriole replaces Mike Sherman, who is retiring from his role as CEO and will become chairman of the board of directors. Martha Demski, the current board chair, will assume the role of lead independent director. These appointments will be effective on August 1.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CMRX:
- Chimerix Announces Promotion of Michael T. Andriole to President and Chief Executive Officer
- Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference
- Chimerix to Participate in Cancer Moonshot Brain Cancers Forum on Glioblastoma (GBM) and Diffuse Intrinsic Pontine Glioma (DIPG) at White House
- Chimerix Reports First Quarter 2023 Financial Results and Provides Operational Update
- Is CMRX a Buy, Before Earnings?